Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients

被引：0

作者：

Masanori Atsukawa

Akihito Tsubota

Noritomo Shimada

Kai Yoshizawa

Hiroshi Abe

Toru Asano

Yusuke Ohkubo

Masahiro Araki

Tadashi Ikegami

Chisa Kondo

Norio Itokawa

Ai Nakagawa

Taeang Arai

Yoko Matsushita

Katsuhisa Nakatsuka

Tomomi Furihata

Yoshimichi Chuganji

Yasushi Matsuzaki

Yoshio Aizawa

Katsuhiko Iwakiri

机构：

[1] Nippon Medical School Chiba Hokusoh Hospital,

[2] Core Research Facilities for Basic Science,undefined

[3] Research Center for Medical Sciences,undefined

[4] Jikei University School of Medicine,undefined

[5] Chiba Tokushukai Hospital,undefined

[6] Machida Municipal Hospital,undefined

[7] Jikei University School of Medicine Katsusika Medical Center,undefined

[8] Tokyo Metropolitan Bokutoh Hospital,undefined

[9] Saiseikai Yokohamashi Tobu Hospital,undefined

[10] Ibaraki Central Hospital,undefined

[11] Kasama,undefined

[12] Tokyo Medical University,undefined

[13] Ibaraki Medical Center,undefined

[14] Nippon Medical School,undefined

[15] Laboratory of Pharmacology and Toxicology,undefined

[16] Graduate School of Pharmaceutical Sciences,undefined

[17] Chiba University,undefined

来源：

BMC Infectious Diseases | / 15卷

关键词：

Chronic hepatitis C; Vitamin D; 25-hydroxyvitamin D;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 51 条

[1]

Shepard CW(2005)Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 558-67

[2]

Finelli L(2010)Telaprevir for previously treated chronic HCV infection N Engl J Med 362 1292-303

[3]

Alter MJ(2011)Boceprevir for untreated chronic HCV genotype 1 infection N Engl J Med 364 1195-206

[4]

McHutchison JG(2012)Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders Hepatology 55 742-48

[5]

Manns MP(2009)Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk Carcinogenesis 30 769-76

[6]

Muir AJ(2010)Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial Br J Nutr 103 549-55

[7]

Terrault NA(2014)Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C Dig Liver Dis 46 738-743

[8]

Jacobson IM(2013)Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial Br J Dermatol 169 434-440

[9]

Afdhal NH(2007)Vitamin D, deficiency N Engl J Med 357 266-81

[10]

Poordad F(1984)1,25-Dihydroxyvitamin D3 receptors in a subset of mitotically active lymphocytes from rat thymus Biochem Biophys Res Commun 121 277-83

← 1 2 3 4 5 6 →